Global Subcutaneous Immunoglobulins Competitive Landscape Professional Research Report 2024

Global Subcutaneous Immunoglobulins Competitive Landscape Professional Research Report 2024



Research Summary

Subcutaneous immunoglobulins (SCIG) refer to a form of immunoglobulin therapy administered via subcutaneous injections just under the skin. These injections deliver concentrated immunoglobulin preparations derived from pooled human plasma to individuals with various conditions characterized by compromised immune function. SCIG therapy is commonly prescribed for individuals with primary immunodeficiency disorders, secondary immunodeficiencies, autoimmune diseases, and certain neurological disorders. By providing a supplemental source of antibodies, SCIG therapy helps bolster the immune system's ability to fight off infections and maintain overall health. It offers a convenient and effective treatment option for individuals who require regular immunoglobulin supplementation to manage their conditions.

According to DIResearch's in-depth investigation and research, the global Subcutaneous Immunoglobulins market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Subcutaneous Immunoglobulins include Shire (Baxalta), Grifols, CSL etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Subcutaneous Immunoglobulins. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Subcutaneous Immunoglobulins market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Subcutaneous Immunoglobulins market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Subcutaneous Immunoglobulins industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Subcutaneous Immunoglobulins Include:

Shire (Baxalta)

Grifols

CSL

Subcutaneous Immunoglobulins Product Segment Include:
0.1g/ml0.2g/ml
Subcutaneous Immunoglobulins Product Application Include:

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Subcutaneous Immunoglobulins Industry PESTEL Analysis

Chapter 3: Global Subcutaneous Immunoglobulins Industry Porter’s Five Forces Analysis

Chapter 4: Global Subcutaneous Immunoglobulins Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Subcutaneous Immunoglobulins Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Subcutaneous Immunoglobulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Subcutaneous Immunoglobulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Subcutaneous Immunoglobulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Subcutaneous Immunoglobulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Subcutaneous Immunoglobulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Subcutaneous Immunoglobulins Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Subcutaneous Immunoglobulins Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Subcutaneous Immunoglobulins Market Overview
1.1 Product Definition and Statistical Scope
1.2 Subcutaneous Immunoglobulins Product by Type
1.2.1 Global Subcutaneous Immunoglobulins Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 0.1g/ml
1.2.3 0.2g/ml
1.3 Subcutaneous Immunoglobulins Product by Application
1.3.1 Global Subcutaneous Immunoglobulins Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Global Subcutaneous Immunoglobulins Market Revenue and Sales Analysis
1.4.1 Global Subcutaneous Immunoglobulins Market Size Analysis (2019-2030)
1.4.2 Global Subcutaneous Immunoglobulins Market Sales Analysis (2019-2030)
1.4.3 Global Subcutaneous Immunoglobulins Market Sales Price Trend Analysis (2019-2030)
1.5 Subcutaneous Immunoglobulins Market Development Status and Trends
1.5.1 Subcutaneous Immunoglobulins Industry Development Status Analysis
1.5.2 Subcutaneous Immunoglobulins Industry Development Trends Analysis
2 Subcutaneous Immunoglobulins Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Subcutaneous Immunoglobulins Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Subcutaneous Immunoglobulins Market Analysis by Regions
4.1 Subcutaneous Immunoglobulins Overall Market: 2023 VS 2024 VS 2030
4.2 Global Subcutaneous Immunoglobulins Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Subcutaneous Immunoglobulins Revenue and Market Share by Region (2019-2024)
4.2.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2025-2030)
4.3 Global Subcutaneous Immunoglobulins Sales and Forecast Analysis (2019-2030)
4.3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Region (2019-2024)
4.3.2 Global Subcutaneous Immunoglobulins Sales Forecast by Region (2025-2030)
4.4 Global Subcutaneous Immunoglobulins Sales Price Trend Analysis (2019-2030)
5 Global Subcutaneous Immunoglobulins Market Size by Type and Application
5.1 Global Subcutaneous Immunoglobulins Market Size by Type
5.1.1 Global Subcutaneous Immunoglobulins Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Subcutaneous Immunoglobulins Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Subcutaneous Immunoglobulins Market Size by Application
5.2.1 Global Subcutaneous Immunoglobulins Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Subcutaneous Immunoglobulins Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Subcutaneous Immunoglobulins Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Subcutaneous Immunoglobulins Market Size by Type
6.3.1 North America Subcutaneous Immunoglobulins Sales by Type (2019-2030)
6.3.2 North America Subcutaneous Immunoglobulins Revenue by Type (2019-2030)
6.4 North America Subcutaneous Immunoglobulins Market Size by Application
6.4.1 North America Subcutaneous Immunoglobulins Sales by Application (2019-2030)
6.4.2 North America Subcutaneous Immunoglobulins Revenue by Application (2019-2030)
6.5 North America Subcutaneous Immunoglobulins Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Subcutaneous Immunoglobulins Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Subcutaneous Immunoglobulins Market Size by Type
7.3.1 Europe Subcutaneous Immunoglobulins Sales by Type (2019-2030)
7.3.2 Europe Subcutaneous Immunoglobulins Revenue by Type (2019-2030)
7.4 Europe Subcutaneous Immunoglobulins Market Size by Application
7.4.1 Europe Subcutaneous Immunoglobulins Sales by Application (2019-2030)
7.4.2  Europe Subcutaneous Immunoglobulins Revenue by Application (2019-2030)
7.5 Europe Subcutaneous Immunoglobulins Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Subcutaneous Immunoglobulins Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Subcutaneous Immunoglobulins Market Size by Type
8.3.1 China Subcutaneous Immunoglobulins Sales by Type (2019-2030)
8.3.2 China Subcutaneous Immunoglobulins Revenue by Type (2019-2030)
8.4 China Subcutaneous Immunoglobulins Market Size by Application
8.4.1 China Subcutaneous Immunoglobulins Sales by Application (2019-2030)
8.4.2 China Subcutaneous Immunoglobulins Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Subcutaneous Immunoglobulins Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Subcutaneous Immunoglobulins Market Size by Type
9.3.1 APAC (excl. China) Subcutaneous Immunoglobulins Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Subcutaneous Immunoglobulins Revenue by Type (2019-2030)
9.4 APAC (excl. China) Subcutaneous Immunoglobulins Market Size by Application
9.4.1 APAC (excl. China) Subcutaneous Immunoglobulins Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Subcutaneous Immunoglobulins Revenue by Application (2019-2030)
9.5 APAC (excl. China) Subcutaneous Immunoglobulins Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Subcutaneous Immunoglobulins Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Subcutaneous Immunoglobulins Market Size by Type
10.3.1 Latin America Subcutaneous Immunoglobulins Sales by Type (2019-2030)
10.3.2 Latin America Subcutaneous Immunoglobulins Revenue by Type (2019-2030)
10.4 Latin America Subcutaneous Immunoglobulins Market Size by Application
10.4.1 Latin America Subcutaneous Immunoglobulins Sales by Application (2019-2030)
10.4.2 Latin America Subcutaneous Immunoglobulins Revenue by Application (2019-2030)
10.5 Latin America Subcutaneous Immunoglobulins Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Subcutaneous Immunoglobulins Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Subcutaneous Immunoglobulins Market Size by Type
11.3.1 Middle East & Africa Subcutaneous Immunoglobulins Sales by Type (2019-2030)
11.3.2 Middle East & Africa Subcutaneous Immunoglobulins Revenue by Type (2019-2030)
11.4 Middle East & Africa Subcutaneous Immunoglobulins Market Size by Application
11.4.1 Middle East & Africa Subcutaneous Immunoglobulins Sales by Application (2019-2030)
11.4.2 Middle East & Africa Subcutaneous Immunoglobulins Revenue by Application (2019-2030)
11.5 Middle East & Africa Subcutaneous Immunoglobulins Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Subcutaneous Immunoglobulins Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Subcutaneous Immunoglobulins Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Subcutaneous Immunoglobulins Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Subcutaneous Immunoglobulins Average Sales Price by Manufacturers (2020-2024)
12.2 Subcutaneous Immunoglobulins Competitive Landscape Analysis and Market Dynamic
12.2.1 Subcutaneous Immunoglobulins Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Shire (Baxalta)
13.1.1 Shire (Baxalta) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio
13.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 Grifols
13.2.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Grifols Subcutaneous Immunoglobulins Product Portfolio
13.2.3 Grifols Subcutaneous Immunoglobulins Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 CSL
13.3.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 CSL Subcutaneous Immunoglobulins Product Portfolio
13.3.3 CSL Subcutaneous Immunoglobulins Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Subcutaneous Immunoglobulins Industry Chain Analysis
14.2 Subcutaneous Immunoglobulins Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Subcutaneous Immunoglobulins Typical Downstream Customers
14.4 Subcutaneous Immunoglobulins Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings